公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | BRK”ing” Down All We Know About PTK6 in Breast Cancer | Yuan, Yi; Ang, Hui Li; Lai, Xianning; Wang, Lingzhi; Pandey, Vijay; Huang, Benjamin BoJun; Tan, Tuan Zea; Chong, Hui Yi; Ong, Philip Zheng Yang; Rangappa, Kanchugarakoppal S.; Arfuso, Frank; Tan, Kevin Shyong-Wei; Basappa, null; Goh, Boon Cher; RUBY YUN-JU HUANG ; Sethi, Gautam; Lobie, Peter E.; Kumar, Alan Prem | | 0 | 0 | |
2023 | The CAM Model—Q&A with Experts | Fischer, Dagmar; Fluegen, Georg; Garcia, Paul; Ghaffari-Tabrizi-Wizsy, Nassim; Gribaldo, Laura; RUBY YUN-JU HUANG ; Rasche, Volker; Ribatti, Domenico; Rousset, Xavier; Pinto, Marta Texeira; Viallet, Jean; Wang, Yan; Schneider-Stock, Regine | Cancers | 12 | | |
2004 | Clinical Presentation of Pelvic Tuberculosis Imitating Ovarian Malignancy | RUBY YUN-JU HUANG ; LING-HUNG WEI ; CHANG-YAO HSIEH | Taiwanese Journal of Obstetrics and Gynecology | 8 | 0 | |
2015 | The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions | Davidson B.; Holth A.; Hellesylt E.; Tan T.Z.; RUBY YUN-JU HUANG ; Trop? C.; Nesland J.M.; Thiery J.P. | Human Pathology | 49 | 45 | |
2016 | A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets | Jia D.; Liu Z.; Deng N.; Tan T.Z.; RUBY YUN-JU HUANG ; Taylor-Harding B.; Cheon D.-J.; Lawrenson K.; Wiedemeyer W.R.; Walts A.E.; Karlan B.Y.; Orsulic S. | Cancer Letters | 83 | 76 | |
2016 | Comparisons of genetic alterations of breast cancer between East and West: Special emphases on young patients with ER /HER2tumors | CHIU-HSUN LIN; Lu, TP; RUBY YUN-JU HUANG ; Lu, YS; Lo, KY; Kuo, KT; Chuang, EY; Wu, PF; Chen, IC; Thiery, JP; Huang, CS; Cheng, AL | CANCER RESEARCH | 0 | 0 | |
2012 | Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial-mesenchymal transition characteristics | HSIN-YU LEE ; Chiang, C.-L.; RUBY YUN-JU HUANG ; Lee, H.; ANDREW WO | NPG Asia Materials | 44 | 43 | |
2011 | Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis | Malek J.A.; Mery E.; Mahmoud Y.A.; Al-Azwani E.K.; Roger L.; RUBY YUN-JU HUANG ; Jouve E.; Lis R.; Thiery J.-P.; Querleu D.; Rafii A. | PLoS ONE | 42 | 38 | |
2020 | Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140 | Sundararajan, Vignesh; Tan, Ming; Tan, Tuan Zea; Pang, Qing You; Ye, Jieru; Chung, Vin Yee; RUBY YUN-JU HUANG | Cancers | 0 | 0 | |
2022 | Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803) | Tai, Yee Kit; Chan, Karen Ka Wing; Fong, Charlene Hui Hua; Ramanan, Sharanya; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Yip, Yun Sheng; Tan, Wei Ren; Koh, Angele Pei Fern; Tan, Nguan Soon; Chan, Ching Wan; RUBY YUN-JU HUANG ; Li, Jing Ze; Fröhlich, Jürg; Franco-Obregón, Alfredo | Frontiers in Oncology | 0 | 0 | |
2015 | CSIOVDB: A microarray gene expression database of epithelial ovarian cancer subtype | Tan T.Z.; Yang H.; Ye J.; Low J.; Choolani M.; Peng Tan D.S.; Thiery J.-P.; RUBY YUN-JU HUANG | Oncotarget | 64 | 59 | |
2020 | Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma Via Oxidative Stress and Iron-Sulfur Cluster Biogenesis Deficit | Novera, Wisna; Lee, Zheng-Wei; Nin, Dawn Sijin; Dai, Melvin Zi-Yu; Binte Idres, Shabana; Wu, Hui; Damen, Mirjam A; Tan, Tuan Zea; Sim, Arthur Yi Loong; Long, Yun Chau; Wu, Wei; RUBY YUN-JU HUANG ; Deng, Lih-Wen | Antioxidants & redox signaling | 20 | 21 | |
2020 | Cytoskeletal proteins in cancer and intracellular stress: A therapeutic perspective | Ong M.S.; Deng S.; Halim C.E.; Cai W.; Tan T.Z.; RUBY YUN-JU HUANG ; Sethi G.; Hooi S.C.; Kumar A.P.; Yap C.T. | Cancers | 57 | 54 | |
2019 | Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer | Tan T.Z.; Heong V.; Ye J.; Lim D.; Low J.; Choolani M.; Scott C.; Tan D.S.P.; RUBY YUN-JU HUANG | Journal of Pathology | 14 | 12 | |
2020 | Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE) | Talhouk A.; George J.; Wang C.; Budden T.; Tan T.Z.; Chiu D.S.; Kommoss S.; Leong H.S.; Chen S.; Intermaggio M.P.; Gilks B.; Nazeran T.M.; Volchek M.; Elatre W.; Bentley R.C.; Senz J.; Lum A.; Chow V.; Sudderuddin H.; Mackenzie R.; Leong S.C.Y.; Liu G.; Johnson D.; Chen B.; Alsop J.; Banerjee S.N.; Behrens S.; Bodelon C.; Brand A.H.; Brinton L.; Carney M.E.; Chiew Y.-E.; Cushing-Haugen K.L.; Cybulski C.; Ennis D.; Fereday S.; Fortner R.T.; Garc?a-Donas J.; Gentry-Maharaj A.; Glasspool R.; Goranova T.; Greene C.S.; Haluska P.; Harris H.R.; Hendley J.; Hernandez B.Y.; Herpel E.; Jimenez-Linan M.; Karpinskyj C.; Kaufmann S.H.; Keeney G.L.; Kennedy C.J.; Kobel M.; Koziak J.M.; Larson M.C.; Lester J.; Lewsley L.-A.; Lissowska J.; Lubi?ski J.; Luk H.; Macintyre G.; Mahner S.; McNeish I.A.; Menkiszak J.; Nevins N.; Osorio A.; Oszurek O.; Palacios J.; Hinsley S.; Pearce C.L.; Pike M.C.; Piskorz A.M.; Ray-Coquard I.; Rhenius V.; Rodriguez-Antona C.; Sharma R.; Sherman M.E.; de Silva D.; Singh N.; Sinn P.; Slamon D.; Song H.; Steed H.; Stronach E.A.; Thompson P.J.; To?oczko A.; Trabert B.; Traficante N.; Tseng C.-C.; Widschwendter M.; Wilkens L.R.; Winham S.J.; Winterhoff B.; Beeghly-Fadiel A.; Benitez J.; Berchuck A.; Brenton J.D.; Brown R.; Chang-Claude J.; Chenevix-Trench G.; deFazio A.; Fasching P.A.; Garc?a M.J.; Gayther S.A.; Goodman M.T.; Gronwald J.; Henderson M.J.; Karlan B.Y.; Kelemen L.E.; Menon U.; Orsulic S.; Pharoah P.D.P.; Wentzensen N.; Wu A.H.; Schildkraut J.M.; Rossing M.A.; Konecny G.E.; Huntsman D.G.; RUBY YUN-JU HUANG ; Goode E.L.; Ramus S.J.; Doherty J.A.; Bowtell D.D.; Anglesio M.S.; AOCS Group | Clinical Cancer Research | 34 | 33 | |
2018 | Dual role of autophagy in hallmarks of cancer | Singh S.S.; Vats S.; Chia A.Y.-Q.; Tan T.Z.; Deng S.; Ong M.S.; Arfuso F.; Yap C.T.; Goh B.C.; Sethi G.; RUBY YUN-JU HUANG ; Shen H.M.; Manjithaya R.; Kumar A.P. | Oncogene | 389 | 354 | |
2012 | Early events in cell adhesion and polarity during epithelialmesenchymal transition | RUBY YUN-JU HUANG ; Guilford P.; Thiery J.P. | Journal of Cell Science | 263 | 247 | |
2020 | Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells | RUBY YUN-JU HUANG ; Yeo, Xun Hui; Tam, Wai Leong | Journal of Clinical Oncology | 0 | 0 | |
2023 | The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer | Yeo, Xun Hui; Sundararajan, Vignesh; Wu, Zhengwei; Phua, Zi Jin Cheryl; Ho, Yin Ying; Peh, Kai Lay Esther; Chiu, Yi-Chia; Tan, Tuan Zea; Kappei, Dennis; Ho, Ying Swan; Tan, David Shao Peng; Tam, Wai Leong; RUBY YUN-JU HUANG | Communications biology | 4 | 1 | |
2017 | The EMT spectrum and therapeutic opportunities | Voon D.C.; RUBY YUN-JU HUANG ; Jackson R.A.; Thiery J.P. | Molecular Oncology | 73 | 71 | |